Literature DB >> 33489904

Salivary Gland Pleomorphic Adenomas Presenting With Extremely Varied Clinical Courses. A Single Institution Case-Control Study.

Krzysztof Piwowarczyk1, Ewelina Bartkowiak1, Paweł Kosikowski2, Jadzia Tin-Tsen Chou1, Małgorzata Wierzbicka1.   

Abstract

OBJECTIVE: Pleomorphic adenomas (PAs) with divergent clinical behavior, differing from the vast majority of PAs, were distinguished. "Fast" PAs are characterized by an unexpectedly short medical history and relatively rapid growth. The reference group consisted of "slow" PAs with very stable biology and long-term progression. We divide the PA group as a whole into three subsets: "fast," "normal," and "slow" tumors. Our goal is a multifactorial analysis of the "fast" and "slow" PA subgroups.
METHODS: Consecutive surgeries in a tertiary referral center, the Department of Otolaryngology and Laryngological Surgery, Poznan University of Medical Sciences, Poland, were carried out between 2002 and 2011. Out of 1,154 parotid tumors, 636 (55.1%) were PAs. The data were collected prospectively in collaboration with the Polish National Registry of Benign Salivary Gland Tumors. The main outcome measure was the recurrence rate in "fast" and "slow" PA subgroups. All surgical qualifications and surgeries were performed by two experienced surgeons.
RESULTS: Slow PAs, compared to fast PAs, presented in older patients (53.25 ± 15.29 versus 47.92 ± 13.44 years). Multifactor logistic regression analysis with recurrence (yes/no) as the outcome variable, fast/slow as the predictor variable and age, gender, margin, FN status as covariates showed that fast PAs were significantly predicting recurrence vs. slow PAs (p = 0.035). Fast PAs were increasing the risk of PAs 10-fold vs. slow PAs, exp β = 10.20, CI95 [1.66; 197.87]. The variables impacting relapse were recent accelerated growth of the tumor OR = 3.35 (SE = 0.56), p = 0.030, positive margins OR = 7.18 (SE = 0.57), p < 0.001, incomplete or bare capsule OR = 9.91 (SE = 0.53), p = 0.001 and location III OR = 3.12 (SE = 0.53), p = 0.033. In the multivariate model only positive margin was selected as the best predictor of relapse, OR = 5.01 (SE = 0.60), p = 0.007.
CONCLUSIONS: The simple clinical aspect of slow or fast PA progression is of great practical importance and can constitute a surrogate of the final histopathological information that is derived from the surgical specimen. The slow or fast nature of the PA to some extent indicates prognostic features such as recurrence risk. This finding requires correlation with histological and molecular features in further stages of research.
Copyright © 2021 Piwowarczyk, Bartkowiak, Kosikowski, Chou and Wierzbicka.

Entities:  

Keywords:  facial nerve; mixed tumor; parotid gland tumor; progression; recurrence; surgery

Year:  2021        PMID: 33489904      PMCID: PMC7820779          DOI: 10.3389/fonc.2020.600707

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  30 in total

1.  [Proliferative activity in recurrent and nonrecurrent pleomorphic adenoma of the salivary glands].

Authors:  D G Bankamp; E Bierhoff
Journal:  Laryngorhinootologie       Date:  1999-02       Impact factor: 1.057

2.  Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients.

Authors:  Claus Wittekindt; Kristina Streubel; Georg Arnold; Eberhard Stennert; Orlando Guntinas-Lichius
Journal:  Head Neck       Date:  2007-09       Impact factor: 3.147

Review 3.  Pleomorphic adenoma of salivary glands: common and uncommon CT and MR imaging features.

Authors:  Hiroki Kato; Masaya Kawaguchi; Tomohiro Ando; Keisuke Mizuta; Mitsuhiro Aoki; Masayuki Matsuo
Journal:  Jpn J Radiol       Date:  2018-05-29       Impact factor: 2.374

4.  Variables related to recurrence of pleomorphic adenomas: outcome of parotid surgery in 182 cases.

Authors:  Magdy Amin Riad; Hussein Abdel-Rahman; Waleed F Ezzat; Ahmad Adly; Ossama Dessouky; Mohamed Shehata
Journal:  Laryngoscope       Date:  2011-06-10       Impact factor: 3.325

5.  Natural history of recurrent pleomorphic adenoma: implications on management.

Authors:  Matthijs H Valstar; Simon Andreasen; Patrick A Bhairosing; Mark McGurk
Journal:  Head Neck       Date:  2020-03-18       Impact factor: 3.147

Review 6.  Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data.

Authors:  Joyce Antony; Vinod Gopalan; Robert A Smith; Alfred K Y Lam
Journal:  Head Neck Pathol       Date:  2011-07-09

7.  Pleomorphic adenoma, I: Ultrastructural organization of "epithelial" regions.

Authors:  I Dardick; A W van Nostrand; M T Jeans; P Rippstein; V Edwards
Journal:  Hum Pathol       Date:  1983-09       Impact factor: 3.466

8.  Satellite tumors surrounding primary pleomorphic adenomas of the parotid gland.

Authors:  Yorihisa Orita; Kazuo Hamaya; Kentaroh Miki; Akiko Sugaya; Misato Hirai; Kiyoko Nakai; Sohichiroh Nose; Tadashi Yoshino
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-07       Impact factor: 2.503

Review 9.  Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables.

Authors:  Pavel Dulguerov; Jelena Todic; Marc Pusztaszeri; Naif H Alotaibi
Journal:  Front Surg       Date:  2017-05-15

10.  Histomorphological comparison of pleomorphic adenoma in major and minor salivary glands of oral cavity: A comparative study.

Authors:  S Nonitha; T L Yogesh; S Nandaprasad; B Uma Maheshwari; I P Mahalakshmi; Bhavana T Veerabasavaiah
Journal:  J Oral Maxillofac Pathol       Date:  2019 Sep-Dec
View more
  3 in total

1.  Global DNA Methylation Profiling Reveals Differentially Methylated CpGs between Salivary Gland Pleomorphic Adenomas with Distinct Clinical Course.

Authors:  Katarzyna Kiwerska; Ewelina Kowal-Wisniewska; Adam Ustaszewski; Ewelina Bartkowiak; Malgorzata Jarmuz-Szymczak; Malgorzata Wierzbicka; Maciej Giefing
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

2.  Tracking of the biochemical changes upon pleomorphic adenoma progression using vibrational microspectroscopy.

Authors:  Czesława Paluszkiewicz; Maciej Roman; Natalia Piergies; Ewa Pięta; Monika Woźniak; Mariangela Cestelli Guidi; Katarzyna Miśkiewicz-Orczyk; Magdalena Marków; Wojciech Ścierski; Maciej Misiołek; Bogna Drozdzowska; Wojciech M Kwiatek
Journal:  Sci Rep       Date:  2021-09-09       Impact factor: 4.379

3.  Expression of p16Ink4a protein in pleomorphic adenoma and carcinoma ex pleomorphic adenoma proves diversity of tumour biology and predicts clinical course.

Authors:  Ewelina Bartkowiak; Krzysztof Piwowarczyk; Magdalena Bodnar; Paweł Kosikowski; Jadzia Chou; Aldona Woźniak; Małgorzata Wierzbicka
Journal:  J Clin Pathol       Date:  2021-05-03       Impact factor: 4.463

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.